Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.

Afficher d'autres versions (1)

The overlapping clinical features of relapsing remitting multiple sclerosis (RRMS), aquaporin-4 (AQP4)-antibody (Ab) neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein (MOG)-Ab disease mean that detection of disease specific serum antibodies is the gold standard...

Description complète

Détails bibliographiques
Auteurs principaux:	Jurynczyk, M, Probert, F, Yeo, T, Tackley, G, Claridge, T, Cavey, A, Woodhall, M, Arora, S, Winkler, T, Schiffer, E, Vincent, A, DeLuca, G, Sibson, N, Leite, M, Waters, P, Anthony, D, Palace, J
Format:	Journal article
Langue:	English
Publié:	BioMed Central 2017

Documents similaires

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
par: Jurynczyk, M, et autres
Publié: (2017)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
par: Maciej Jurynczyk, et autres
Publié: (2017-12-01)

Distinguishing the brain MRI features of MS, AQP4-and MOG-antibody disease.
par: Jurynczyk, M, et autres
Publié: (2016)

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
par: Juryńczyk, M, et autres
Publié: (2016)

RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES
par: Elsone, L, et autres
Publié: (2014)

Classifying the antibody-negative NMO syndromes: Clinical, imaging, and metabolomic modeling
par: Yeo, T, et autres
Publié: (2019)

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies
par: Yeo, T, et autres
Publié: (2020)

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies
par: Tianrong Yeo, et autres
Publié: (2020-03-01)

Disease course and disability outcomes in MOG-antibody disease in the UK
par: Jurynczyk, M, et autres
Publié: (2017)

Clinical presentation and prognosis in MOG-antibody disease: a UK study
par: Jurynczyk, M, et autres
Publié: (2017)

International multicenter examination of MOG antibody assays
par: Reindl, M, et autres
Publié: (2020)

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
par: Sato, D, et autres
Publié: (2014)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
par: Waters, P, et autres
Publié: (2015)

Recurrent optic neuritis associated with MOG antibody seropositivity
par: Chang, T, et autres
Publié: (2017)

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
par: Kezuka, T, et autres
Publié: (2014)

A Longitudinal Comparison of the Recovery Patterns of Optic Neuritis with MOG Antibody-Seropositive and AQP4 Antibody-Seropositive or -Seronegative for Both Antibodies
par: Lin Zhou, et autres
Publié: (2022-01-01)

Value of Area Postrema Syndrome in Differentiating Adults With AQP4 vs. MOG Antibodies
par: Jae-Won Hyun, et autres
Publié: (2020-06-01)

Prevalence of serum MOG antibody and AQP4 antibody in optic neuritis after SARS-CoV-2 infection
par: Chuan-bin Sun
Publié: (2023-11-01)

An international multicentre validation experiment for MOG antibodies
par: Reindl, M, et autres
Publié: (2018)

Features of the diagnosis and treatment of patients with AQP-4-positive neuromyelitis optica and MOG antibody disease
par: V. E. Avdeeva, et autres
Publié: (2021-11-01)

MOG-IgG1 antibodies in children
par: Waters, P, et autres
Publié: (2018)

A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies.
par: Morris, K, et autres
Publié: (2015)

Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.
par: Piccolo, L, et autres
Publié: (2016)

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
par: Waters, P, et autres
Publié: (2015)

Predictors of relapse in MOG antibody associated disease: a cohort study
par: Saif Huda, et autres
Publié: (2021-11-01)

Case report: Satralizumab as an adjunctive therapy for AQP-4 antibody and MOG antibody dual-negative optic neuritis in a third-trimester pregnancy case
par: Chuanbin Sun, et autres
Publié: (2024-12-01)

Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
par: Xuelian Chen, et autres
Publié: (2023-03-01)

No strong HLA association with MOG antibody disease in the UK population
par: Grant-Peters, M, et autres
Publié: (2021)

Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis
par: Tackley, G, et autres
Publié: (2016)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
par: Jarius, S, et autres
Publié: (2018)

Corrigendum: Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
par: Xuelian Chen, et autres
Publié: (2023-08-01)

MOG antibody associated disorder (MOGAD)
par: Lilley Kate, et autres
Publié: (2021-01-01)

Epilepsy in patients with MOG antibody disease
par: Varvara E. Avdeeva, et autres
Publié: (2021-10-01)

No strong HLA association with MOG antibody disease in the UK population
par: Melissa Grant‐Peters, et autres
Publié: (2021-07-01)

Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies
par: Elisabeth Maillart, et autres
Publié: (2020-04-01)

Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method
par: Luca Bollo, et autres
Publié: (2021-03-01)

Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies.
par: Kaneko, K, et autres
Publié: (2016)

Understanding MOG antibody-associated disease in Brazil
par: Dagoberto Callegaro, et autres
Publié: (2023-11-01)

AQP4 antibody assay sensitivity comparison in the era of the 2015 diagnostic criteria for NMOSD
par: Prain, K, et autres
Publié: (2019)

Pediatric MOG antibody-positive encephalitis with normal brain magnetic resonance imaging: a new spectrum associated with MOG antibodies?
par: Yan Jiang, et autres
Publié: (2025-02-01)